COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization.

Piché-Renaud, Pierre-Philippe; Swayze, Sarah; Buchan, Sarah A; Wilson, Sarah E; Austin, Peter C; Morris, Shaun K; Nasreen, Sharifa; Schwartz, Kevin L; Tadrous, Mina; Thampi, Nisha; Wilson, Kumanan; Kwong, Jeffrey C

Piché-Renaud, Pierre-Philippe; Swayze, Sarah; Buchan, Sarah A; Wilson, Sarah E; Austin, Peter C; Morris, Shaun K; Nasreen, Sharifa; Schwartz, Kevin L; Tadrous, Mina; Thampi, Nisha; Wilson, Kumanan; Kwong, Jeffrey C.

Afiliação

Piché-Renaud PP; Division of Pediatric Infectious Diseases, The Hospital for Sick Children, Toronto, Ontario, Canada.
Swayze S; Institute for Health, Policy, Management and Evaluation.
Buchan SA; ICES, Toronto, Ontario, Canada.
Wilson SE; Dalla Lana School of Public Health.
Austin PC; Centre for Vaccine Preventable Diseases.
Morris SK; ICES, Toronto, Ontario, Canada.
Nasreen S; Public Health Ontario, Toronto, Ontario, Canada.
Schwartz KL; Dalla Lana School of Public Health.
Tadrous M; Centre for Vaccine Preventable Diseases.
Thampi N; ICES, Toronto, Ontario, Canada.
Wilson K; Public Health Ontario, Toronto, Ontario, Canada.
Kwong JC; Institute for Health, Policy, Management and Evaluation.

Pediatrics ; 151(4)2023 04 01.

Article em En | MEDLINE | ID: mdl-36866446

Assuntos

Vacinas contra COVID-19; COVID-19; Criança; Humanos; Vacina BNT162; Eficácia de Vacinas; COVID-19/prevenção & controle; Hospitalização

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Child / Humans Idioma: En Revista: Pediatrics Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google